VIENNA, AUSTRIA, AND RIJSWIJK, THE NETHERLANDS – Lexogen and BlueBee, global experts in transcriptome sequencing and bioinformatics, respectively, have announced the implementation of the CORALL Total RNA-Seq data analysis pipeline on the BlueBee platform. Released by Lexogen earlier this year, CORALL is a novel all-in-one RNA-Seq Library Prep Kit, which enables fast and cost-efficient generation of UMI-labelled […]
INTEGRA Biosciences has a suite of products designed to lower the cost of PCR setup and NGS library preparation. From Clear Advantage™ multichannel reagent reservoirs to VOYAGER adjustable tip spacing electronic multichannel pipettes, the company’s products can help to ensure efficient and reliable pipetting while reducing experimental costs. As the price of NGS equipment has […]
FOR IMMEDIATE RELEASE System Integrates Thermo Scientific KingFisherâ„¢ Presto for Rapid Processing of Calcified Tissues and Other Challenging Samples Reno, Nev. – The new ID NIMBUS® Presto assay ready workstation from Hamilton Company offers fast, hands-free nucleic acid extraction of high-volume evidentiary samples such as calcified tissues and other challenging samples. The compact system is conveniently pre-configured and qualified […]
Pay Invoice
Latest Blogs
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
-
Steady Demand in the Industrial Market for Analytical and Scientific Instrumentation
July 30, 2024 3:07 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.